Log in to save to my catalogue

Impact of 68Ga-PSMA PET/CT on salvage radiotherapy planning in patients with prostate cancer and per...

Impact of 68Ga-PSMA PET/CT on salvage radiotherapy planning in patients with prostate cancer and per...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5081978

Impact of 68Ga-PSMA PET/CT on salvage radiotherapy planning in patients with prostate cancer and persisting PSA values or biochemical relapse after prostatectomy

About this item

Full title

Impact of 68Ga-PSMA PET/CT on salvage radiotherapy planning in patients with prostate cancer and persisting PSA values or biochemical relapse after prostatectomy

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

Journal title

EJNMMI research, 2016-10, Vol.6 (1), Article 78

Language

English

Formats

Publication information

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

More information

Scope and Contents

Contents

Background
Salvage radiotherapy (SRT) is clinically established in prostate cancer (PC) patients with PSA persistence or biochemical relapse (BCR) after prior radical surgery. PET/CT imaging prior to SRT may be performed to localize disease recurrence. The recently introduced
68
Ga-PSMA outperforms other PET tracers for detection of recurr...

Alternative Titles

Full title

Impact of 68Ga-PSMA PET/CT on salvage radiotherapy planning in patients with prostate cancer and persisting PSA values or biochemical relapse after prostatectomy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5081978

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5081978

Other Identifiers

ISSN

2191-219X

E-ISSN

2191-219X

DOI

10.1186/s13550-016-0233-4

How to access this item